lecanemab biosimilar
/ CSPC Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 25, 2025
LECANEMAB INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
(CSPC Press Release)
New trial • Alzheimer's Disease
1 to 1
Of
1
Go to page
1